Formoterol and budesonide inhibit rhinovirus infection and cytokine production in primary cultures of human tracheal epithelial cells

Respiratory Investigation

Volumn 52, Issue 4, 2014, Pages 251-260

  Yamaya, Mutsuo ^a   Nishimura, Hidekazu ^b   Nadine, Lusamba ^a   Kubo, Hiroshi ^a   Nagatomi, Ryoichi ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b SENDAI CITY MEDICAL CENTER   (Japan)

Author keywords

Inhaled corticosteroid; Intercellular adhesion molecule; Rhinovirus; Tracheal epithelial cell

Indexed keywords

BUDESONIDE; FORMOTEROL; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; TRANSCRIPTION FACTOR RELA; VIRUS RNA; 3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; VIRUS RECEPTOR; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CYTOKINE; ETHANOLAMINE DERIVATIVE; GLUCOCORTICOID;

AGED; ANTIVIRAL ACTIVITY; ARTICLE; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; DRUG POTENTIATION; EMBRYO; ENDOSOME; EPITHELIUM CELL; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; INFECTION SENSITIVITY; INTERCELLULAR ADHESION MOLECULE 1 GENE; MALE; NONHUMAN; PROTEIN EXPRESSION; RHINOVIRUS INFECTION; TRACHEA MUCOSA; VIRUS INHIBITION; VIRUS RELEASE; VIRUS REPLICATION; VIRUS TITRATION; ACIDITY; ANTIINFLAMMATORY ACTIVITY; CELL COUNT; CELL CULTURE; CELL NUCLEUS; CYTOPLASM; DISEASE ASSOCIATION; FLUORESCENCE ANALYSIS; HUMAN RHINOVIRUS B14; RESPIRATORY TRACT INFLAMMATION; RNA TRANSPORT; SUPERNATANT; VIRUS LOAD; CYTOLOGY; DRUG EFFECTS; GENETICS; METABOLISM; PATHOGENICITY; PHYSIOLOGY; PICORNAVIRUS INFECTION; RHINOVIRUS; TRACHEA; VIROLOGY;

ADRENERGIC BETA-2 RECEPTOR AGONISTS; AGED; BUDESONIDE; CELLS, CULTURED; CYTOKINES; EPITHELIAL CELLS; ETHANOLAMINES; FEMALE; GLUCOCORTICOIDS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MALE; PICORNAVIRIDAE INFECTIONS; RHINOVIRUS; RNA, VIRAL; TRACHEA; TRANSCRIPTION FACTOR RELA; VIRUS REPLICATION;

EID: 84903751692     PISSN: 22125345     EISSN: 22125353     Source Type: Journal    
DOI: 10.1016/j.resinv.2014.03.004     Document Type: Article

References (49)

1. Turner RB, Couch RB. Rhinoviruses. Fields virology 2006, 895-909. Lippincott Williams and Wilkins, Philadelphia, PA. 5th ed. D.M. Knipe, P.M. Howley (Eds.).
2. Seemungal T, Harper-Owen R, Bhowmik A, et al. Detection of rhinovirus in induced sputum at exacerbation of chronic obstructive pulmonary disease. Eur Respir J 2000, 16:677-683.
3. Johnston SL, Pattemore PK, Sanderson G, et al. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. Br Med J 1995, 310:1225-1229.
4. Pizzichini MMM, Pizzichini E, Efthimiadis A, et al. Asthma and natural colds. Inflammatory indices in induced sputum: a feasibility study. Am J Respir Crit Care Med 1998, 158:1178-1184.
5. Subauste MC, Jacoby DB, Richards SM, et al. Infection of a human respiratory epithelial cell line with rhinovirus. Induction of cytokine release and modulation of susceptibility to infection by cytokine exposure. J Clin Invest 1995, 96:549-557.
6. Zhu Z, Tang W, Ray A, et al. Rhinovirus stimulation of interleukin-6 in vivo and in vitro. Evidence for nuclear factor κB-dependent transcriptional activation. J Clin Invest 1996, 97:421-430.
7. Calverley PM, Boonsawat W, Cseke Z, et al. Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease. Eur Respir J 2003, 22:912-919.
8. Calverley PM, Anderson JA, Celli B, et al. TORCH investigators. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007, 356:775-789.
9. Pauwels RA, Lofdahl CG, Postma DS, et al. Effects of inhaled formoterol and budesonide on exacerbations of asthma. N Engl J Med 1997, 337:1405-1411.
10. 2 agonists differentially regulate rhinovirus-induced interleukin-6 via distinct cis-acting elements. J Biol Chem 2007, 282:15366-15375.
11. Skevaki CL, Christodoulou I, Spyridaki IS, et al. Budesonide and formoterol inhibit inflammatory mediator production by bronchial epithelial cells infected with rhinovirus. Clin Exp Allergy 2009, 39:1700-1710.
12. Edwards MR, Johnson MW, Johnston SL. Combination therapy: synergistic suppression of virus-induced chemokines in airway epithelial cells. Am J Respir Cell Mol Biol 2006, 34:616-624.
13. Casasnovas JM, Springer TA. Pathway of rhinovirus disruption by soluble intercellular adhesion molecule 1 (ICAM-1): an intermediate in which ICAM-1 is bound and RNA is released. J Virol 1994, 68:5882-5889.
14. Greve JM, Davis G, Meyer AM, et al. The major human rhinovirus receptor is ICAM-1. Cell 1989, 56:839-847.
15. Sabatini F, Silvestri M, Scarso L, et al. The antiinflammatory activity of budesonide on human airway epithelial cells is lasting after removal of the drug from cultures. J Asthma 2002, 39:11-20.
16. Olivieri D, Chetta A, Del Donno M, et al. Effect of short-term treatment with low-dose inhaled fluticasone propionate on airway inflammation and remodeling in mild asthma: a placebo-controlled study. Am J Respir Crit Care Med 1997, 155:1864-1871.
17. Yamaya M, Nishimura H, Hatachi Y, et al. Procaterol inhibits rhinovirus infection in primary cultures of human tracheal epithelial cells. Eur J Pharmacol 2011, 650:431-444.
18. Yamaya M, Nishimura H, Nadine L, et al. Tulobuterol inhibits rhinovirus infection in primary cultures of human tracheal epithelial cells. Physiol Rep 2013, 1:e00041.
19. Bochkov Y, Busse WW, Brockman-Schneider RA, et al. Budesonide and formoterol effects on rhinovirus replication and epithelial cell cytokine responses. Respir Res 2013, 14:98.
20. Numazaki Y, Oshima T, Ohmi A, et al. A microplate methods for isolation of viruses from infants and children with acute respiratory infections. Microbiol Immunol 1987, 31:1085-1095.
21. Condit RC. Principles of virology. Fields virology 2006, 25-57. Lippincott Williams and Wilkins, Philadelphia, PA. 5th ed. D.M. Knipe, P.M. Howley (Eds.).
22. Nolan T, Hands RE, Bustin SA. Quantification of mRNA using real-time RT-PCR. Nat Protoc 2006, 1:1559-1582.
23. Suzuki T, Yamaya M, Sekizawa K, et al. Erythromycin inhibits rhinovirus infection in cultured human tracheal epithelial cells. Am J Respir Crit Care Med 2002, 165:1113-1118.
24. Van den Bosch JM, Westermann CJ, Aumann J, et al. Relationship between lung tissue and blood plasma concentrations of inhaled budesonide. Biopharm Drug Dispos 1993, 14:455-459.
25. Campestrini J, Lecaillon JB, Godbillon J. Automated and sensitive method for the determination of formoterol in human plasma by high-performance liquid chromatography and electrochemical detection. J Chromatogr B 1997, 704:221-229.
26. 2-selective adrenoceptor antagonist (ICI 118,551). J Cardiovasc Pharmacol 1983, 5:430-437.
27. Gravett CM, Theron AJ, Steel HC, et al. Interactive inhibitory effects of formoterol and montelukast on activated human neutrophils. Eur Respir J 2010, 36:1417-1424.
28. Roos AB, Barton JL, Miller-Larsson A, et al. Lung epithelial-C/EBP contributes to LPS-induced inflammation and its suppression by formoterol. Biochem Biophys Res Commun 2012, 423:134-139.
29. Hoshino M, Ohtawa J. Effects of budesonide/formoterol combination therapy versus budesonide alone on airway dimensions in asthma. Respirology 2012, 17:639-646.
30. Riise GC, Larsson S, Lofdahl CG, et al. Circulating cell adhesion molecules in bronchial lavage and serum in COPD patients with chronic bronchitis. Eur Respir J 1994, 7:1673-1677.
31. Grunberg K, Sterk PJ. Rhinovirus infections: induction and modulation of airways inflammation in asthma. Clin Exp Allergy 1999, 29(Suppl. 2):S65-S73.
32. 2-adrenoceptor agonist. J Asthma 1998, 35:401-408.
33. Silvestri M, Fregonese L, Sabatini F, et al. Fluticasone and salmeterol downregulate in vitro, fibroblast proliferation and ICAM-1 or H-CAM expression. Eur Respir J 2001, 18:139-145.
34. Spoelstra FM, Postma DS, Hovenga H, et al. Additive anti-inflammatory effect of formoterol and budesonide on human lung fibroblasts. Thorax 2002, 57:237-241.
35. Slack RJ, Barrett VJ, Morrison VS, et al. In vitro pharmacological characterization of vilanterol, a novel long-acting 2-adrenoceptor agonist with 24-hour duration of action. J Pharmacol Exp Ther 2013, 344:218-230.
36. Gerlo S, Kooijman R, Beck IM, et al. Cyclic AMP: a selective modulator of NF-kB action. Cell Mol Life Sci 2011, 68:3823-3841.
37. Papi A, Johnston SL. Respiratory epithelial cell expression of vascular cell adhesion molecule-1 and its up-regulation by rhinovirus infection via NF-κB and GATA transcription factors. J Biol Chem 1999, 274:30041-30051.
38. Wilson SJ, Wallin A, Della-Cioppa G, et al. Effects of budesonide and formoterol on NF-kappaB, adhesion molecules, and cytokines in asthma. Am J Respir Crit Care Med 2001, 164:1047-1052.
39. Baouz S, Giron-Michel J, Azzarone B, et al. Lung myofibroblasts as targets of salmeterol and fluticasone propionate: inhibition of α-SMA and NF-kappaB. Int Immunol 2005, 17:1473-1481.
40. Antal JM, Divis LT, Erzurum SC, et al. Surfactant suppresses NF-kappa B activation in human monocytic cells. Am J Respir Cell Mol Biol 1996, 14:374-379.
41. Kesanakurti D, Chetty C, Rajasekhar Maddirela D, et al. Essential role of cooperative NF-kB and Stat3 recruitment to ICAM-1 intronic consensus elements in the regulation of radiation-induced invasion and migration in glioma. Oncogene 2013, 32:5144-5155.
42. 2-adrenergic receptor agonist and corticosteroid of Staphylococcus aureus-induced airway inflammatory mediator production. Am J Physiol 2006, 291:L11-L18.
43. Mathur SK, Fichtinger PS, Kelly JT, et al. Interaction between allergy and innate immunity: model for eosinophil regulation of epithelial cell interferon expression. Ann Allerg Asthma Immunol 2013, 111:25-31.
44. Watkins DN, Peroni DJ, Basclain KA, et al. Expression and activity of nitric oxide synthases in human airway epithelium. Am J Respir Cell Mol Biol 1997, 16:629-639.
45. Terajima M, Yamaya M, Sekizawa K, et al. Rhinovirus infection of primary cultures of human tracheal epithelium: role of ICAM-1 and IL-1β. Am J Physiol 1997, 273:L749-L759.
46. Mellman I, Fuchs R, Helenius A. Acidification of the endocytic and exocytic pathways. Ann Rev Biochem 1986, 55:663-700.
47. + exchanger in a late endosomal compartment of yeast. Implications for vacuole biogenesis. J Biol Chem 1998, 273:21054-21060.
48. Gekle M, Serrano OK, Drumm K, et al. NHE3 serves as a molecular tool for cAMP-mediated regulation of receptor-mediated endocytosis. Am J Physiol 2002, 283:F549-F558.
49. Schneider D, Ganesan S, Comstock AT, et al. Increased cytokine response of rhinovirus-infected airway epithelial cells in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010, 182:332-340.